ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency.
If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal COVID-19 vaccine".
In January 2022, India's drug controller had given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal vaccine.
During an interview with Mint in April, Ella had said that the initial results of the phase III trials are promising and the intranasal covid-19 vaccine is a game-changer. “Our intranasal covid-19 vaccine is a game-changer as it will prevent infection and the transmission of the disease.